Ocrelizumab Intravenous and Hepatitis B
Result of checking the interaction of drug Ocrelizumab Intravenous and disease Hepatitis B for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of ocrelizumab is contraindicated in patients with an active hepatitis B virus (HBV) infection. It is recommended to consult a liver disease expert before starting and during treatment with ocrelizumab in patients who are negative for surface antigen [HBsAg] and positive for HB core antibody [HBcAb+] or are carriers of HBV [HBsAg+].
Generic Name: ocrelizumab
Brand Name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
Ocrelizumab Intravenous - zapalenie wątroby typu B 
Ocrelizumab Intravenous - hepatite B 
Ocrelizumab Intravenous - Hepatitis B 
Ocrelizumab Intravenous - hepatitis B 
Ocrelizumab Intravenous - epatite B 
Ocrelizumab Intravenous - hépatite B 
Ocrelizumab Intravenous - Hepatitis B. 
Ocrelizumab Intravenous - hepatitis B 
Ocrelizumab Intravenous - гепатит Б 
Ocrelizumab Intravenous - Hepatit B 
Ocrelizumab Intravenous - التهاب الكبد ب 
Ocrelizumab Intravenous - 乙肝